(Q46988910)

English

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

scientific article published on 14 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures (English)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

author name string

Mack CM

1

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Moore CX

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Jodka CM

3

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Bhavsar S

4

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Wilson JK

5

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Hoyt JA

6

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Roan JL

7

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Vu C

8

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Laugero KD

9

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Parkes DG

10

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

Young AA

11

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

language of work or name

0 references

publication date

14 March 2006

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

International Journal of Obesity

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

30

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

9

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

1332-1340

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803284

0 references

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 and satiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Central pre-proglucagon derived peptides: opportunities for treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Is parental control over children's eating associated with childhood obesity? Results from a population-based sample of third graders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Pica in rats is analogous to emesis: an animal model in emesis research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Macronutrient diet selection in thirteen mouse strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803284

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.IJO.0803284

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16534527

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46988910&oldid=2140979603"